| Scrip Code | 544476 |
|---|---|
| NSE Symbol | JSLL |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0J5801029 |
| Name of company | JEENA SIKHO LIFECARE LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 07-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 03-02-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 07-02-2026 16:05:00 |
| End date and time of board meeting | 07-02-2026 16:35:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 22,167.97 | 58,581.07 | |
| Other income | 256.68 | 508.02 | |
| Total income | 22,424.65 | 59,089.09 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 2,601.90 | 7,251.62 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (182.09) | (589.50) |
| (d) | Employee benefit expense | 3,928.86 | 10,241.88 |
| (e) | Finance costs | 310.04 | 910.65 |
| (f) | Depreciation, depletion and amortisation expense | 1,125.95 | 3,130.81 |
| (f) | Other Expenses | ||
| 1 | Other Expenditure | 5,746.90 | 14,526.89 |
| Total other expenses | 5,746.90 | 14,526.89 | |
| Total expenses | 13,531.56 | 35,472.35 | |
| 3 | Total profit before exceptional items and tax | 8,893.09 | 23,616.74 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 8,893.09 | 23,616.74 |
| 6 | Tax expense | ||
| 7 | Current tax | 2,398.18 | 6,228.64 |
| 8 | Deferred tax | (164.98) | (273.94) |
| 9 | Total tax expenses | 2,233.20 | 5,954.70 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 6,659.89 | 17,662.04 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 6,659.89 | 17,662.04 |
| 17 | Other comprehensive income net of taxes | 2.90 | 53.94 |
| 18 | Total Comprehensive Income for the period | 6,662.79 | 17,715.98 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 6,666.09 | 17,671.95 | |
| Total profit or loss, attributable to non-controlling interests | (6.20) | (9.91) | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 6,668.99 | 17,725.89 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | (6.20) | (9.91) | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2,486.01 | 2,486.01 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 5.36 | 14.21 | |
| Diluted earnings (loss) per share from continuing operations | 5.35 | 14.19 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 5.36 | 14.21 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 5.35 | 14.19 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | ||
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Ayurvedic products/medicines | 12,176.52 | 29,771.30 | ||||
| 2 | Ayurvedic Healthcare Sevices | 9,989.95 | 28,808.27 | ||||
| 3 | Others | 0.000015 | 0.000015 | ||||
| Total Segment Revenue | 22,167.97 | 58,581.07 | |||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | 22,167.97 | 58,581.07 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Ayurvedic products/medicines | 5,316.32 | 12,511.21 | ||||
| 2 | Ayurvedic Healthcare Sevices | 4,104.75 | 12,806.54 | ||||
| 3 | Others | (12.88) | (20.41) | ||||
| Total Profit before tax | 9,408.19 | 25,297.34 | |||||
| i. Finance cost | 309.91 | 910.49 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 205.19 | 770.11 | |||||
| Profit before tax | 8,893.09 | 23,616.74 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Ayurvedic products/medicines | 0.00 | 0.00 | ||||
| 2 | Ayurvedic Healthcare Sevices | 0.00 | 0.00 | ||||
| 3 | Others | 0.00 | 0.00 | ||||
| Total Segment Asset | 0.00 | 0.00 | |||||
| Un-allocable Assets | 0.00 | 0.00 | |||||
| Net Segment Asset | 0.00 | 0.00 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Ayurvedic products/medicines | 0.00 | 0.00 | ||||
| 2 | Ayurvedic Healthcare Sevices | 0.00 | 0.00 | ||||
| 3 | Others | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 0.00 | 0.00 | |||||
| Un-allocable Liabilities | 0.00 | 0.00 | |||||
| Net Segment Liabilities | 0.00 | 0.00 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gains/(loss) on defined benefit plan | 3.87 | 72.08 |
| Total Amount of items that will not be reclassified to profit and loss | 3.87 | 72.08 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 0.97 | 18.14 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| Total Amount of items that will be reclassified to profit and loss | |||
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 2.90 | 53.94 |